Laboratorios Bagó S.A.
Laboratorios Bagó S.A., a prominent player in the pharmaceutical industry, is headquartered in Argentina (AR) and operates extensively across Latin America and beyond. Founded in 1934, the company has established itself as a leader in the development and manufacturing of high-quality medications, particularly in the fields of cardiology, oncology, and infectious diseases. With a diverse portfolio that includes prescription drugs, over-the-counter products, and innovative biopharmaceuticals, Laboratorios Bagó is recognised for its commitment to research and development. The company’s unique approach to product formulation and quality assurance has earned it a strong market position, making it a trusted name among healthcare professionals and patients alike. Notable achievements include significant contributions to public health initiatives and a robust presence in both domestic and international markets.
DitchCarbon Score
How does Laboratorios Bagó S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laboratorios Bagó S.A.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laboratorios Bagó S.A.'s reported carbon emissions
Laboratorios Bagó S.A., headquartered in Argentina, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Laboratorios Bagó S.A. may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Laboratorios Bagó S.A. to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratorios Bagó S.A. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
